Rac1 Is Required for Oncolytic NDV Replication in Human Cancer Cells and Establishes a Link Between Tumorigenesis and Sensitivity to Oncolytic Virus

Oncogene - United Kingdom
doi 10.1038/onc.2009.507
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hypoxia Enhances the Replication of Oncolytic Herpes Simplex Virus in P53- Breast Cancer Cells

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells

PLoS ONE
Multidisciplinary
2014English

Oncolytic Potency and Reduced Virus Tumor-Specificity in Oncolytic Virotherapy. A Mathematical Modelling Approach

PLoS ONE
Multidisciplinary
2017English

Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

An Oncolytic Virus Expressing a T-Cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells

Cancer Research
Cancer ResearchOncology
2018English

Sensitivity of Breast Tumors to Oncolytic Viruses

2005English

Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2012English

Oncolytic Virotherapy: Molecular Targets in Tumor-Selective Replication and Carrier Cell-Mediated Delivery of Oncolytic Viruses

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2008English

Oncolytic Herpes Virus Retargeted to HER-2

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy